Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) and Pfizer (PFE) Could Make Headlines At The World Muscle Society Conference - Nomura

September 24, 2018 6:27 AM
Nomura/Instinet analyst, Christopher Marai, reiterated his Buy rating on shares of Sarepta Therapeutics (NASDAQ: SRPT) ahead of the World Muscle ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments